FDA clears digital therapeutic for abdominal pain from IBS
MetaMe received FDA clearance for its first digital therapeutic on Tuesday. It uses behavioral therapy to help alleviate abdominal pain symptoms for patients with irritable bowel syndrome.
MetaMe raises $3.8M to create a hypnosis-based DTX for your IBS
The company's lead product Regulora delivers a standardized 12-week therapy which bring patients into a state of deep relaxation and suggestibility before using metaphors and stories to create a sense of comfort and ease around the individual's condition and symptoms.
presented by
RCM Outsourcing: Balancing Human Expertise & Smart Technology
Greenway Health blends smart technology with human expertise to elevate revenue cycle.